News | February 04, 2026
Wanbury achieves first sales invoicing and commercial shipment milestone
This achievement validates global demand and catapults Wanbury into high-growth acceleration
This achievement validates global demand and catapults Wanbury into high-growth acceleration
The development marks an important step in Sigachi's strategic focus on expanding its presence in complex, high-value specialty APIs, aligned with global demand for advanced therapies in rare and chronic disease segments
The Eugene facility, with more than 20 years of history, houses a 16,000-square-foot R&D lab and a newly constructed 30,000-square-foot manufacturing facility
India should explore Sustainability-Linked Incentives (SLI) targeting innovations in the 12 principles of green chemistry
GSK will make most of its inhaled respiratory portfolio and other products available on a direct purchasing platform, offering savings of up to 66%
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
The approval of Augmentin XR, granted to USAntibiotics, directly supports the CNPV program’s goals
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
The new site will produce next-generation synthetic medicine active pharmaceutical ingredients
Subscribe To Our Newsletter & Stay Updated
